Experienced international business executive and board member, capable of bringing value on a wide range of strategic, operational and organizational issues to companies of all sizes, from start-ups to multi-nationals, with particular expertise and knowledge in biotechnology and pharmaceuticals. Strong finance professional and Audit Committee Member/Chairperson. CPA. Qualified financial expert with expertise in accounting, finance, risk and assurance. Dual MBA in Finance and Marketing. Thirty years of progressive experience including successful national, regional and global finance roles in public accounting, corporate operations, manufacturing, commercial, marketing, market access, audit, international business, and biologics discovery & development areas. Most recent tenures include CFO of the biologics division of a top ten global biopharmaceutical company, Chief Audit Executive for a FTSE10 company and VP of Finance for Asia-Pacific Region. Board experience includes being Non-Executive Director on the Board of Directors and Audit Committee Member for Verona Pharma plc (Nasdaq: VRNA); Non-Executive Director on the Board of Directors and Audit Committee Chairperson for Panavance Therapeutics Inc. Member of the Portfolio Oversight Advisory Panel of a stealth venture capital entity investing in innovative early stage therapeutics. Former Board Member, Executive Committee Member and Finance and Audit Committee Chairperson for The Montgomery County Economic Development Corporation. Internal Board experience includes multiple internal Boards and Committees, including Boards of acquired entities and Chairperson of Pension Investment Committee. Selected for the 2021 Agenda Diversity 100 List and BoardProspects' 2024 list of 75 LGBTQ+ Board Members Making a Difference.